A study of the safety, absorption and effects of investigational drug ARV-102 in patients with Parkinson's disease.

Status

Completed

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2024-516888-84-00

Acronym

ARV-102-103

Enrollment

Registered

2024-10-29

Start date

2024-11-12

Completion date

2025-12-23

Last updated

2025-07-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson's disease.

None listed

Sex/Gender

All

Age

18 Years to No maximum

Netherlands

None listed

Source: EU CTIS · Data processed: Feb 4, 2026